Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 2

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 4Endocrine 2

Conditions

Neuroendocrine Tumors 69Carcinoma, Neuroendocrine 26Pheochromocytoma 23Thyroid Cancer, Papillary 21Pituitary Neoplasms 21Thyroid Neoplasms 20Adrenocortical Carcinoma 18Paraganglioma 15Multiple Endocrine Neoplasia Type 1 12Sarcoma 11Neuroblastoma 11Small Cell Lung Carcinoma 10Neoplasms 10Melanoma 9Lung Neoplasms 9Carcinoid Tumor 9Adrenal Gland Neoplasms 9Adenoma, Islet Cell 9Pancreatic Neoplasms 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Medullary 8Adenocarcinoma, Follicular 8Thyroid Carcinoma, Anaplastic 7Ovarian Neoplasms 7Neoplasm Metastasis 7Cushing Syndrome 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Breast Neoplasms 7

Interventions

fluorocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hyperparathyroidism, Primary × Endocrine × 90 days × Clear all
NCT07444723 2026-06-02

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

NCT04969926 2026-05-12

Natural History Study of Parathyroid Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
3,000 enrolled
EndocrineHead & Neck

Hyperparathyroidism, Parathyroid Neoplasms, Pseudohypoparathyroidism, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡